Publications by authors named "Xiao-Yan Nie"

Article Synopsis
  • Pharmacoeconomic evaluation aims to improve drug safety and effectiveness by optimizing healthcare resource utilization and supporting better decision-making in healthcare.
  • Chinese patent medicine is a crucial part of China’s healthcare system, but its post-marketing economic evaluations are often lacking in standardization and quality.
  • A project led by experts is developing guidelines to enhance the methodology and standardization of pharmacoeconomic evaluations for Chinese patent medicine, ensuring alignment with existing regulations and traditional Chinese medicine principles.
View Article and Find Full Text PDF

Hyperlipidemia, an important risk factor for cardiovascular and end-stage renal diseases, often aggravates renal injury and compromises kidney function. Here, histological analysis of human kidney samples revealed that high lipid levels induced the development of renal fibrosis. To elucidate the mechanism underlying lipid nephrotoxicity, we used two types of mouse models (Apoe and C57BL/6 mice fed a 45 and 60% high-fat diet, respectively).

View Article and Find Full Text PDF

Background The clinical pharmacist has been an important partner in clinical treatment team. In China, there is no systematic review to evaluate the effectiveness of clinical pharmacy services on patients' outcomes such as hospitalization days, readmission rate and mortality. Aim of the review To investigate the impact of clinical pharmacist services on patients' length of hospitalization, readmission and mortality in China.

View Article and Find Full Text PDF

This study aimed to evaluate the cost-effectiveness of loss-of-function(LOF) allele-guided antiplatelet therapy compared with the universal use of clopidogrel or ticagrelor among Chinese patients with acute coronary syndrome undergoing percutaneous coronary intervention. A two-part cost-effectiveness model comprising of a 1-year decision tree and a long-term Markov model was utilized to simulate outcomes of three treatment strategies: universal use of clopidogrel (75 mg daily) or universal use of ticagrelor 90 mg twice daily for all patients and LOF-guided therapy (LOF allele carriers receiving ticagrelor, LOF allele noncarriers receiving clopidogrel). Model outcomes included quality-adjusted life years (QALYs) gained, direct medical costs and incremental cost-effectiveness ratios (ICERs).

View Article and Find Full Text PDF

Objective: Investigate the association between P2Y12 Purinoceptor (P2RY12) polymorphisms and adverse clinical events in coronary artery disease (CAD) patients treated with clopidogrel.

Methods: We performed a comprehensive database search, with a particular focus on P2RY12 polymorphisms and their effects on clopidogrel-treated CAD patients, in the PubMed, EMBASE, Cochrane Library, clinicaltrials.gov, Web of Science, and Chinese databases from their inceptions to April 8, 2017.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to explore how specific genetic variations (polymorphisms) in the PEAR1 gene relate to cardiovascular outcomes in patients with acute coronary syndrome (ACS) who are on aspirin and clopidogrel treatment.
  • Researchers analyzed eight common PEAR1 SNPs along with CYP2C19 genetic variants in 196 Chinese ACS patients, noting significant associations between certain mutations and the effectiveness of platelet inhibition and the occurrence of ischemic events over a year.
  • Findings suggest that specific genetic markers, like the T allele in rs11264579, may reduce the risk of ischemic events, while the A allele in rs822442 is linked to an increased risk, indicating potential genetic influences
View Article and Find Full Text PDF

Objective: To investigate a possible association between common variations of the P2RY12 and the residual clopidogrel on-treatment platelet reactivity after adjusting for the influence of CYP2C19 tested by thromboelastography (TEG).

Methods: One hundred and eighty patients with acute coronary syndrome (ACS) treated with clopidogrel and aspirin were included and platelet function was assessed by TEG. Five selected P2RY12 single nucleotide polymorphisms (SNPs; rs6798347, rs6787801, rs6801273, rs6785930, and rs2046934), which cover the common variations in the P2RY12 gene and its regulatory regions, and three CYP2C19 SNPs (2,3,17) were genotyped and possible haplotypes were analyzed.

View Article and Find Full Text PDF

Background: To investigate the contributions of CYP2C19 polymorphisms to the various clopidogrel responses tested by thrombelastography (TEG) in Chinese patients with the acute coronary syndrome (ACS).

Methods: Patients were screened prospectively with ACS diagnose and were treated with clopidogrel and aspirin dual antiplatelet therapy. CYP2C19 loss of function (LOF) and gain of function (GOF) genotype, adenosine 5'-diphosphate (ADP)-channel platelet inhibition rate (PIR) tested by TEG and the occurrence of 3-month major adverse cardiovascular events and ischemic events were assessed in 116 patients.

View Article and Find Full Text PDF

Pharmacy education in China focuses on pharmaceutical sciences, with the bachelor of science (BS) of pharmacy as the entry-level degree. Pharmacy practice curricula in these programs are centered on compounding, dispensing, pharmacy administration, and laboratory experiences, which are the traditional responsibilities for pharmacists. Additional graduate-level training is available at the master of science (MS) and the doctor of philosophy (PhD) levels, most of which concentrate on drug discovery and drug development research.

View Article and Find Full Text PDF

In the title mononuclear complex, [Ni(C(8)H(7)O(3))(2)(C(3)H(4)N(2))(2)], the Ni(II) atom, lying on a twofold rotation axis, is coordinated by four carboxyl-ate O atoms from two bidentate 3-hydroxy-phenylacetato ligands and two N atoms from two imidazole mol-ecules in a distorted octa-hedral geometry. A three-dimensional network is formed via inter-molecular O-H⋯O and N-H⋯O hydrogen bonds and π-π stacking inter-actions between the imidazole and benzene rings of neighboring mol-ecules [centroid-centroid distance = 3.856 (2) Å].

View Article and Find Full Text PDF

The asymmetric unit of the title compound, {[AgNd(C(6)H(4)NO(2))(2)(C(2)O(4))]·2H(2)O}(n), contains one Nd(III) atom, one Ag(I) atom, one oxalate ligand, two nicotinate ligands and two uncoordinated water mol-ecules. The Nd(III) atom is eight-coordinated in a distorted square-anti-prismatic coordination geometry by four O atoms from two oxalate ligands and four O atoms from four nicotinate ligands. The Ag(I) atom has a T-shaped configuration, defined by two N atoms from two nicotinate ligands and one O atom from one oxalate ligand.

View Article and Find Full Text PDF
Bis(pyridine-3-carboxylic acid-κN)silver(I) perchlorate.

Acta Crystallogr Sect E Struct Rep Online

January 2009

In the title compound, [Ag(C(6)H(5)NO(2))(2)]ClO(4), the Ag(I) atom shows an almost linear coordination geometry, defined by two N atoms from two pyridine-3-carboxylic acid ligands. The complex cations are linked by hydrogen bonds between the carboxyl groups into a chain. The chains are further connected through C-H⋯O hydrogen bonds and a weak Ag⋯O inter-action [2.

View Article and Find Full Text PDF

The clinical benefits of coronary artery bypass graft operations can be compromised by postoperative vasospasm. Traditionally, local papaverine (PPV) has been employed during the procedure to prevent and counteract vasospasm. But the relatively short action period limited its application.

View Article and Find Full Text PDF

The gene encoding the Ig-like domain of tyrosine protein kinase receptor EphB2 was cloned into the expressing vector pET28a. Under induction with IPTG, the positive strain expressed the fusion protein with a hexahistidine tail on the N-terminal. The protein was purified under denaturing conditions using metal chelate chromatography.

View Article and Find Full Text PDF